INTRODUCTION
Cell-mediated immunity in vivo results in allograft destruction, in graft versus host reactions following bone marrow transplantation, in delayed type hypersensitivity responses to mycobacteria and other antigens, in autoimmune or autoaggressive diseases and in immunity to tumors, allogeneic or syngeneic.1.2 Natural cellular immunity-also known as cellular natural killing (CNK)-has been described recently in man-5 and in mice."
The possible role of both CNK and cell-mediated immunity through "sensitization" process is one of the current topics in both clinical and basic immunology. Especially, the nature of target cells in relation to CNK is presently subject to extensive research.
In the previous paper, we first demonstrated CNK against 'normal' cells, using human thymocytes as target cells.10 In this article we studied CNK against human thymocytes more in detail from the aspect of individual difference in CNK activity. CNK against autologous and xenogeneic thymoc yytes was also examined in addition to cytotoxicity against allogeneic thymocytes.
MATERIALS AND METHODS
Target Cells. The human thymuses were obtained from five patients with heart disease who have undergone open surgery (4 cases of children and 1 adult case). After the removal of thymic capsula, the thymus was cut into 5 mm slices and teased on a cell filter to extract thymus cells. Thymocyte suspensions were then prepared by the method of Boyum.11 The mouse thymocytes from C57Bi/6J strain (the Jackson Laboratory, Bar Harbor, Maine) were also prepared by the same procedure. •¡ ; CNK activity Sp. R.; Spontaneous release used as targets on the same day they were obtained from surgery or cryopre served thawed thymocytes were unsuitable targets due to poor 51Cr incorpora tion and rapid spontaneous release, and poor sensitivity to CNK was observed.
However, prestimulation with PHA-P 1 µg/ml for from 2 to 4 days resulted in a highly viable population of cells, incorporating up to 20 fold more 51Cr than non-PHA stimulated cultures on day 0. These PHA-prestimulated thymocyte targets showed a good sensitivity to CNK and low spontaneous release.
CNK Activity of Human PBL against Allogeneic Thymocytes. Individual Difference in CNK Activity and No Relation to HLA-The cytotoxicity of human PBL to PHA stimulated allogeneic thymocytes was examined on 20 normal indi viduals, 10 male and 10 female, ranging in age from 21 to 53 years. -1.7 to 41.7% of cytotoxicity was observed, individual to individual (Fig. 2) . While indi vidual response to each allogeneic thymocytes is variable, the intensity in gen- observed in CNK between male and female effectors (P<0.001).
Concerning age, no conclusion was drawn since most donors used in these experiments were in their twenties.
Comparison of CNK Activity between Thymocytes and Tumor Cells-Target Cytotoxicity. According to the above experiments, the 20 donors can be divided into 3 groups in terms of degree of effector activity against PHA-stimulated allogeneic thymocytes.
CNK activity of these donors against leukemic T-cells Dose Dependent Cytotoxicity in CNK. The dose dependent cytotoxicity in CNK was examined, as shown in Fig. 4 . Thymocytes, HSB leukemic T-cells and SB cultured B-cells were used as targets.
PBL from different individuals were used as effectors. PBL from donors of differing HLA phenotype, excluding low responder group, exhibited high cytotoxic activity against thymocytes and HSB T-cell targets in all ratio tested, and had comparatively low activity against SB B-cell targets.
Although HSB and SB were established from the same individual and are therefore identical for their HLA and presumably for other cell surface major histocompatibility, their reactivities differ markedly.
show cytotoxicity against autologous thymocytes target at all E/T ratios tested. Negative CNK against Peripheral Blood Leukocytes. Normal PBL from Thymocytes-E.A., HSB leukemic T-cells, and SB cultured B-cells were used as targets. CNK activities were studied at E/T ratio, from 100 to 6. Table  1 PBL from four individuals were stimulated in culture with PHA-P at 1 It/ml for 3 days, then labelled with 51Cr and used as target cells in the cytotoxic assay. Two fresh PBL were also used. The ratio of effector cells to targets was 50:1 throughout.
The standard deviation of triplicate cultures was ±2% of the mean. Table 2 Cryopreserved thymocytes from five heart diseases were used as targets in these experiments.
PBL of these heart patients were used as effectors on 7 days after the operation.
No immuno-suppressive drugs were administrated in these patients. CNK Activity against Autologous Thymocytes. In addition to the above allogeneic effector and target interaction, next, the autologous combination of peripheral blood and thymus lymphocytes was examined ( Table 2 ). The lym phocytes of 3 donors with heart disease were examined on CNK against auto logous thymocytes.
The lymphocytes did not show the cytotoxicity to the own thymocytes.
However, by depleting phagocytic cells, lymphocytes of case No. 2 (female, 35 years old) induced cytotoxicity (10.0%) to her own thymus lym phocytes. These 3 donors in this experiment are thought to belong to low re sponders, because they did not show strong cytotoxicity to allogenic thymocytes, although case No. 1 induced strong cytotoxicity to leukemic T-cell.
Positive CNK of Xenogeneic Lymphocytes against Thymocytes. Fig. 5 pres ents CNK activities of xenogeneic lymphocytes against thymocytes.
In experi ment A, human thymocytes were used as targets, and as effectors both human PBL and mouse spleen cells were used. In experiment B, mouse thymocytes were used as targets.
Effectors Both human and mouse thymocytes (C57Bl/ 6J) were used as targets. As effectors, human PBL and mouse spleen cells were studied, in both untreated and phagocytes de pleted. In regard to human effectors, high responder against allogeneic thymocytes -PBL) and low responder PBL) were studied. 
DISCUSSION
Naturally occurring antibodies to thymocytes have been described in mice and rats.14,15 Naturally occurring antibodies to tumors also have been studied in various species including man e•7 Concerning natural cell-mediated immunity, tumor cells have been mainly used as targets.3,7 It was interesting for us to study natural cellular immunity against thymocytes, since the clear evidence is getting aggregated that the thymus usually works as a target organ in autoimmune dis- 2) PHA-prestimulated thymocytes target showed a good sensitivity in CNK c experiments. 3) CNK against thymocytes varied individual to individual.
The high re sponders in CNK against thymocytes induced strong cytotoxicity against leukemic T-cells. The low responders showed very weak CNK activity against leukemic T-cells. The CNK activity against thymocytes was not correlated with HLA. Thymocytes were more strongly lysed by male lymphocytes than by female ones.
4)
CNK against peripheral blood leukocytes was not observed. 
